U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07894939) titled 'Post-Marketing Surveillance to Evaluate the Safety and Effectiveness of Zastaprazan Citrate... Read More
U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07896200) titled 'Comparison of Outcomes of Microscopic Mastoidectomy With and Without Check Endoscopy' on Oc... Read More
U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07894965) titled 'Dual-Task Core Stabilization Training in Chronic Nonspecific Low Back Pain' on Oct. 19. Br... Read More
U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07893951) titled 'Comparison of Open vs Laparoscopic Repair of Perforated Duodenal Ulcer' on Oct. 07. Brief ... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A longitudinal study to investigate innate immune reprogramming following Herpes Zoster vaccinatio... Read More
U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07894952) titled 'Implementing IVM for Fertility Treatment in Clinical Practice' on Oct. 07. Brief Summary: ... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'Phase I/II study of Mezigdomide and Elranatamab for relapsed/refractory multiple myeloma patients ... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'Phase Ib/II Study of Tislelizumab in Combination with Bevacizumab and Capecitabine in Advanced Sol... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose St... Read More
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Multicenter, Open-Label, First-in-Human Study to Evaluate the Safety, Tolerability, Pha... Read More